June 23, 2026 · Form 4 insider transaction
Janku Filip bought 6,000 shares of Monte Rosa Therapeutics, Inc. at $7.56 per share, a transaction worth $45.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2026.